Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cepharanthine in Asymptomatic or Mild COVID-19
NCT05398705Phase 2Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- May 2022
- Primary completion
- Aug 2022
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cepharanthine in coronavirus disease 2019 (COVID-19), sponsored by Shanghai Jiao Tong University School of Medicine. Started May 2022; status: completed.
02
Drugs
cepharanthine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05398705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05398705.